Jupiter Neurosciences, Inc.
JUNS
$3.20
-$0.08-2.44%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -20.53% | -10.99% | -76.17% | 788.68% | 651.14% |
| Gross Profit | 23.72% | 14.98% | 87.01% | -788.68% | -651.14% |
| SG&A Expenses | 43.73% | 46.20% | 121.31% | 268.63% | 230.13% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.18% | 28.85% | 94.09% | 365.47% | 306.55% |
| Operating Income | -21.10% | -27.63% | -92.59% | -365.47% | -306.55% |
| Income Before Tax | -0.95% | -34.87% | -68.57% | -287.14% | -819.58% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.95% | -34.87% | -68.57% | -287.14% | -819.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -0.95% | -34.87% | -68.57% | -287.14% | -819.58% |
| EBIT | -21.10% | -27.63% | -92.59% | -365.47% | -306.55% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 19.90% | -26.64% | -39.70% | -253.30% | -697.14% |
| Normalized Basic EPS | 0.56% | -26.71% | -65.18% | -253.31% | -192.73% |
| EPS Diluted | 19.90% | -26.64% | -40.37% | -253.30% | -778.99% |
| Normalized Diluted EPS | 0.56% | -26.71% | -65.18% | -253.31% | -225.21% |
| Average Basic Shares Outstanding | 26.04% | 6.50% | 20.67% | 9.58% | 20.51% |
| Average Diluted Shares Outstanding | 26.04% | 6.50% | 20.67% | 9.58% | 8.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |